A growing number of researchers are investigating whether GLP-1 receptor agonists, a class of medications widely used to treat type 2 diabetes and obesity, may also
Scientists at ETH Zurich have reported encouraging results from an experimental drug designed to target a newly identified mechanism involved in Alzheimer’s disease. The research
Researchers at Washington University School of Medicine in St. Louis have developed a promising new blood test that uses artificial intelligence to help distinguish among several
Story By Chris Nakea Vice Chair & Public Image Officer, Alzheimer’s/Dementia Rotary Action Group (ADRAG) It began on a quiet afternoon in May 2011 on Martha’s Vineyard,
One of the greatest challenges facing families affected by Alzheimer’s disease and other forms of dementia is finding ways to help loved ones remain independent while
